Stay updated on BMS-986205 Immuno-Therapy Combo Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 Immuno-Therapy Combo Clinical Trial page.

Latest updates to the BMS-986205 Immuno-Therapy Combo Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page shows a new revision label: Revision: v3.3.4, replacing v3.3.3. This appears to be a metadata/version update rather than a change to core content, pricing, stock availability, or time slot availability. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe study locations were expanded with new sites across the US, Canada, Australia, and Poland, and several previously listed locations were removed. The page revision now shows Revision: v3.3.3.SummaryDifference2%

- Check52 days agoChange DetectedRevision: v3.3.2 added, replacing the previous Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now shows a new Revision: v3.3.1, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

- Check66 days agoChange DetectedRemoved the site-wide government funding notice that previously warned about potential delays and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedOnly minor UI/layout changes are visible, with core study data and eligibility criteria remaining the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to BMS-986205 Immuno-Therapy Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 Immuno-Therapy Combo Clinical Trial page.